Search
Search Results
##search.searchResults.foundPlural##
-
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1747PDF: 814HTML: 220 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1573PDF: 570HTML: 370 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2395HTML: 9387DOCX: 993Tables Dengue: 204 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6252PDF: 2088HTML: 13993Untitled: 194figure: 178 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1321PDF: 825HTML: 10033cover letter to the editor: 164tile page: 245 -
Pseudo-differentiation syndrome
1331PDF: 651HTML: 10837Figure 1: peripheral blood showing myeloblasts with auer rods: 115Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 100Figure 3: CXR showing pulmonary infiltartes with consolidation: 134Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 106Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 114 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
935PDF: 1199HTML: 100 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1209PDF: 968HTML: 198 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1811HTML: 1418PDF: 1067 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3000PDF: 1019HTML: 3067 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2366PDF: 847HTML: 2448 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1437PDF: 745Suppl. Files: 315Html: 130 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1355PDF: 676HTML: 1072Untitled: 175Untitled: 146Untitled: 126Untitled: 147Untitled: 157 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
912PDF: 452HTML: 108 -
Severe Acute Hepatitis B Treated with Entecavir
1496PDF: 779HTML: 2466Figure: 164Title page: 170disclosure: 102 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2047PDF: 1500HTML: 265 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1113PDF: 468HTML: 309 -
A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq Characterization of COVID-19 in Kurdistan Region, Iraq
1172PDF: 821HTML: 220 -
Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination
1073PDF: 547HTML: 211 -
Sterile "Abscess" of the Spleen and the Sickle Cell Trait
2791PDF: 687HTML: 819 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1650PDF: 713HTML: 2331 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1238PDF: 853HTML: 273 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3295PDF: 1017HTML: 995Figure 1: 168 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4726PDF: 1878HTML: 11029Fig 1: 218Fig 2: 177Fig 3: 296Fig 4: 182Fig 5: 174Fig 6: 169Fig 7: 183Fig 8: 176 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1660PDF: 1152HTML: 239 -
Osteolytic bone lesions – A rare presentation of AML M6.
1957PDF: 1085HTML: 7910Untitled: 200







